Status:
UNKNOWN
Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
There is a considerable variation in the disease behavior in terms of contracting the infection, manifesting none to a range of symptoms and severity of the infection among individuals exposed to or i...
Eligibility Criteria
Inclusion
- Male or female over 18 years of age at the time of enrollment
- Have symptoms of COVID-19 (with or without hospitalization) or contact history
- Willing to undergo nasopharyngeal swab test for viral-RNA at baseline (in non-hospitalized cases) and the MoCA survey at baseline and 1-month follow-up
Exclusion
- Unwilling to provide informed consent
- MoCA score ≤17 at baseline
- Patients with clinical diagnosis of dementia
- Impaired consciousness
Key Trial Info
Start Date :
August 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04506229
Start Date
August 20 2020
End Date
September 1 2021
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Cardiac Arrhythmia Institute
Austin, Texas, United States, 78705